Emerging Monogenic Complex Hyperkinetic Disorders

Miryam Carecchio, Niccolò E. Mencacci

Research output: Contribution to journalReview article

17 Citations (Scopus)

Abstract

Purpose of Review: Hyperkinetic movement disorders can manifest alone or as part of complex phenotypes. In the era of next-generation sequencing (NGS), the list of monogenic complex movement disorders is rapidly growing. This review will explore the main features of these newly identified conditions. Recent Findings: Mutations in ADCY5 and PDE10A have been identified as important causes of childhood-onset dyskinesias and KMT2B mutations as one of the most frequent causes of complex dystonia in children. The delineation of the phenotypic spectrum associated with mutations in ATP1A3, FOXG1, GNAO1, GRIN1, FRRS1L, and TBC1D24 is revealing an expanding genetic overlap between epileptic encephalopathies, developmental delay/intellectual disability, and hyperkinetic movement disorders,. Summary: Thanks to NGS, the etiology of several complex hyperkinetic movement disorders has been elucidated. Importantly, NGS is changing the way clinicians diagnose these complex conditions. Shared molecular pathways, involved in early stages of brain development and normal synaptic transmission, underlie basal ganglia dysfunction, epilepsy, and other neurodevelopmental disorders.

Original languageEnglish
Article number97
JournalCurrent Neurology and Neuroscience Reports
Volume17
Issue number12
DOIs
Publication statusPublished - Dec 1 2017

Fingerprint

Movement Disorders
Hyperkinesis
Mutation
Dystonia
Dyskinesias
Brain Diseases
Basal Ganglia
Synaptic Transmission
Intellectual Disability
Epilepsy
Phenotype
Brain

Keywords

  • Epilepsy
  • Genetics
  • Hyperkinetic
  • Movement disorders
  • Next-generation sequencing

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology

Cite this

Emerging Monogenic Complex Hyperkinetic Disorders. / Carecchio, Miryam; Mencacci, Niccolò E.

In: Current Neurology and Neuroscience Reports, Vol. 17, No. 12, 97, 01.12.2017.

Research output: Contribution to journalReview article

Carecchio, Miryam ; Mencacci, Niccolò E. / Emerging Monogenic Complex Hyperkinetic Disorders. In: Current Neurology and Neuroscience Reports. 2017 ; Vol. 17, No. 12.
@article{70f7d007134247539bb98aed52ee5519,
title = "Emerging Monogenic Complex Hyperkinetic Disorders",
abstract = "Purpose of Review: Hyperkinetic movement disorders can manifest alone or as part of complex phenotypes. In the era of next-generation sequencing (NGS), the list of monogenic complex movement disorders is rapidly growing. This review will explore the main features of these newly identified conditions. Recent Findings: Mutations in ADCY5 and PDE10A have been identified as important causes of childhood-onset dyskinesias and KMT2B mutations as one of the most frequent causes of complex dystonia in children. The delineation of the phenotypic spectrum associated with mutations in ATP1A3, FOXG1, GNAO1, GRIN1, FRRS1L, and TBC1D24 is revealing an expanding genetic overlap between epileptic encephalopathies, developmental delay/intellectual disability, and hyperkinetic movement disorders,. Summary: Thanks to NGS, the etiology of several complex hyperkinetic movement disorders has been elucidated. Importantly, NGS is changing the way clinicians diagnose these complex conditions. Shared molecular pathways, involved in early stages of brain development and normal synaptic transmission, underlie basal ganglia dysfunction, epilepsy, and other neurodevelopmental disorders.",
keywords = "Epilepsy, Genetics, Hyperkinetic, Movement disorders, Next-generation sequencing",
author = "Miryam Carecchio and Mencacci, {Niccol{\`o} E.}",
year = "2017",
month = "12",
day = "1",
doi = "10.1007/s11910-017-0806-2",
language = "English",
volume = "17",
journal = "Current Neurology and Neuroscience Reports",
issn = "1528-4042",
publisher = "Current Medicine Group",
number = "12",

}

TY - JOUR

T1 - Emerging Monogenic Complex Hyperkinetic Disorders

AU - Carecchio, Miryam

AU - Mencacci, Niccolò E.

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Purpose of Review: Hyperkinetic movement disorders can manifest alone or as part of complex phenotypes. In the era of next-generation sequencing (NGS), the list of monogenic complex movement disorders is rapidly growing. This review will explore the main features of these newly identified conditions. Recent Findings: Mutations in ADCY5 and PDE10A have been identified as important causes of childhood-onset dyskinesias and KMT2B mutations as one of the most frequent causes of complex dystonia in children. The delineation of the phenotypic spectrum associated with mutations in ATP1A3, FOXG1, GNAO1, GRIN1, FRRS1L, and TBC1D24 is revealing an expanding genetic overlap between epileptic encephalopathies, developmental delay/intellectual disability, and hyperkinetic movement disorders,. Summary: Thanks to NGS, the etiology of several complex hyperkinetic movement disorders has been elucidated. Importantly, NGS is changing the way clinicians diagnose these complex conditions. Shared molecular pathways, involved in early stages of brain development and normal synaptic transmission, underlie basal ganglia dysfunction, epilepsy, and other neurodevelopmental disorders.

AB - Purpose of Review: Hyperkinetic movement disorders can manifest alone or as part of complex phenotypes. In the era of next-generation sequencing (NGS), the list of monogenic complex movement disorders is rapidly growing. This review will explore the main features of these newly identified conditions. Recent Findings: Mutations in ADCY5 and PDE10A have been identified as important causes of childhood-onset dyskinesias and KMT2B mutations as one of the most frequent causes of complex dystonia in children. The delineation of the phenotypic spectrum associated with mutations in ATP1A3, FOXG1, GNAO1, GRIN1, FRRS1L, and TBC1D24 is revealing an expanding genetic overlap between epileptic encephalopathies, developmental delay/intellectual disability, and hyperkinetic movement disorders,. Summary: Thanks to NGS, the etiology of several complex hyperkinetic movement disorders has been elucidated. Importantly, NGS is changing the way clinicians diagnose these complex conditions. Shared molecular pathways, involved in early stages of brain development and normal synaptic transmission, underlie basal ganglia dysfunction, epilepsy, and other neurodevelopmental disorders.

KW - Epilepsy

KW - Genetics

KW - Hyperkinetic

KW - Movement disorders

KW - Next-generation sequencing

UR - http://www.scopus.com/inward/record.url?scp=85032706032&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032706032&partnerID=8YFLogxK

U2 - 10.1007/s11910-017-0806-2

DO - 10.1007/s11910-017-0806-2

M3 - Review article

AN - SCOPUS:85032706032

VL - 17

JO - Current Neurology and Neuroscience Reports

JF - Current Neurology and Neuroscience Reports

SN - 1528-4042

IS - 12

M1 - 97

ER -